Cashu
Corcept Therapeutics' Leadership Reaffirms Growth Confidence with Stock Option Exercise
5 days ago
Stocks
Health Care
cort
Corcept Therapeutics
NASDAQ: CORT
-0.02 (-0.03%)
71.36
USD
At close at Sep 03, 20:09 UTC
Latest Corcept Therapeutics News
benzinga.com
Witnessing An Insider Decision, Gary Charles Robb Exercises Options Valued At $328K At Corcept Therapeutics
7 days ago
benzinga.com
A Look at Axsome Therapeutics's Upcoming Earnings Report
about 1 month ago
benzinga.com
A Glimpse of Teva Pharmaceutical Indus's Earnings Potential
about 1 month ago
benzinga.com
What's Driving the Market Sentiment Around Corcept Therapeutics?
about 2 months ago
benzinga.com
Insider Decision: Gary Charles Robb Offloads $225K Worth Of Corcept Therapeutics Stock
3 months ago
benzinga.com
Major Update: LEONARD BAKER JR At Corcept Therapeutics Exercises Options, Realizing $0
3 months ago
businesswire.com
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results, Provide Corporate Update and Host Conference Call
7 months ago
businesswire.com
Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients With Hypercortisolism
8 months ago
businesswire.com
Corcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing’s Syndrome) and Difficult-to-Control Diabetes
9 months ago
businesswire.com
Corcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing’s Syndrome) and Difficult-to-Control Diabetes
9 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.